A detailed history of Caldwell Trust CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Caldwell Trust CO holds 347 shares of AZN stock, worth $30,917. This represents 0.0% of its overall portfolio holdings.

Number of Shares
347
Previous 347 -0.0%
Holding current value
$30,917
Previous $24.2 Million 9.79%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Sep 22, 2025

BUY
$64.87 - $75.0 $22,509 - $26,025
347 New
347 $24.2 Million
Q1 2025

Sep 23, 2025

BUY
$65.37 - $77.96 $65 - $77
1 Added 0.29%
348 $25.6 Million
Q3 2024

Sep 24, 2025

BUY
$76.67 - $87.62 $6,210 - $7,097
81 New
81 $6.31 Million
Q2 2024

Sep 24, 2025

SELL
$66.81 - $80.83 $19,040 - $23,036
-285 Closed
0 $0
Q1 2024

Sep 24, 2025

SELL
$61.03 - $69.57 $3,783 - $4,313
-62 Reduced 17.87%
285 $19.3 Million
Q4 2023

Oct 01, 2025

BUY
$61.89 - $69.28 $5,198 - $5,819
84 Added 29.47%
369 $24.9 Million
Q1 2023

Oct 01, 2025

SELL
$63.15 - $71.6 $3,915 - $4,439
-62 Reduced 17.87%
285 $19.8 Million
Q4 2022

Oct 01, 2025

SELL
$54.21 - $70.44 $3,361 - $4,367
-62 Reduced 17.87%
285 $19.3 Million
Q3 2021

Oct 02, 2025

SELL
$55.56 - $60.79 $2,611 - $2,857
-47 Closed
0 $0
Q1 2021

Oct 02, 2025

SELL
$47.16 - $54.44 $14,147 - $16,332
-300 Reduced 86.46%
47 $2.34 Million
Q4 2020

Oct 02, 2025

SELL
$48.52 - $58.02 $14,556 - $17,406
-300 Reduced 86.46%
47 $2.35 Million
Q3 2020

Oct 02, 2025

SELL
$53.07 - $61.1 $26,216 - $30,183
-494 Reduced 91.31%
47 $2.58 Million
Q2 2020

Oct 02, 2025

SELL
$43.1 - $55.31 $86 - $110
-2 Reduced 0.37%
541 $28.6 Million
Q1 2020

Oct 02, 2025

BUY
$37.79 - $51.33 $7,406 - $10,060
196 Added 56.48%
543 $24.3 Million
Q4 2019

Oct 06, 2025

BUY
$42.46 - $50.46 $8,322 - $9,890
196 Added 56.48%
543 $27.1 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $276B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Caldwell Trust CO Portfolio

Follow Caldwell Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caldwell Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Caldwell Trust CO with notifications on news.